The global at-home testing market is poised for remarkable growth, with sales projected to rise from USD 7,789.1 million in 2025 to USD 11,877.8 million by 2035, according to recent market analysis.

ACIP is recommending that adults aged 50 to 59 years who are at increased risk for severe RSV disease receive a single dose of an RSV vaccine.

The seasonal timing of when infants receive the new respiratory syncytial virus (RSV) immunization is crucial for ensuring ...

CDC director Mandy Cohen said the drug "provides parents with a powerful tool to protect their children against the threat of RSV", which, according to agency data, hospitalises somewhere between ...

Protection against RSV among infants and birthing parents differed by race and ethnicity, indicating the need to ensure equitable access to RSV products.

The delayed meeting of the CDC's main vaccines advisory committee has taken place, with new recommendations on respiratory syncytial virus (RSV) vaccines that do away with restrictions imposed ...

A phase 3 trial involving nearly 25,000 older adults across 17 countries found that a single dose of the RSVPreF3 OA vaccine ...

"The symptoms can be pretty severe and if you are immune compromised it could lead to a need for hospital treatment," said Dr. Blatt. The CDC emphasizes the importance of protection against ...

Meeting, held April 24–28 in Honolulu, reveals that young children with chronic conditions are more likely to be hospitalized ...

Rates of the bacterial infection have gone up by 500% since last year, with babies and young children most at risk.

Young children with chronic conditions are more likely to be hospitalized for respiratory syncytial virus (RSV) than healthy children, according to a new study.